Pharmacogenetics: From Bench to Byte— An Update of Guidelines
@article{Swen2011PharmacogeneticsFB, title={Pharmacogenetics: From Bench to Byte— An Update of Guidelines}, author={J. Swen and M. Nijenhuis and A. Boer and L. Grandia and A. Maitland‐van der Zee and H. Mulder and G. Rongen and R. Schaik and T. Schalekamp and D. Touw and J. Weide and B. Wilffert and V.H.M. Deneer and H. Guchelaar}, journal={Clinical Pharmacology & Therapeutics}, year={2011}, volume={89} }
Currently, there are very few guidelines linking the results of pharmacogenetic tests to specific therapeutic recommendations. Therefore, the Royal Dutch Association for the Advancement of Pharmacy established the Pharmacogenetics Working Group with the objective of developing pharmacogenetics‐based therapeutic (dose) recommendations. After systematic review of the literature, recommendations were developed for 53 drugs associated with genes coding for CYP2D6, CYP2C19, CYP2C9, thiopurine‐S… CONTINUE READING
Topics from this paper
Paper Mentions
Blog Post
707 Citations
Pharmacogenetics of anti-cancer drugs: State of the art and implementation - recommendations of the French National Network of Pharmacogenetics.
- Medicine
- Therapie
- 2017
- 13
Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for Dihydropyrimidine Dehydrogenase Genotype and Fluoropyrimidine Dosing: 2017 Update
- Medicine
- Clinical pharmacology and therapeutics
- 2018
- 140
- PDF
Cytochrome P450 genotype‐guided drug therapies: An update on current states
- Medicine
- Clinical and experimental pharmacology & physiology
- 2018
- 13
Pharmacogenetics implementation in the clinics: information and guidelines for germline variants
- Medicine
- 2019
- 5
- Highly Influenced
- PDF
Clinical pharmacogenetics implementation consortium guideline (CPIC) for CYP2D6 and CYP2C19 genotypes and dosing of tricyclic antidepressants: 2016 update
- Medicine
- Clinical pharmacology and therapeutics
- 2017
- 219
- PDF
Pharmacogenomics guidelines: Current status and future development
- Medicine
- Clinical and experimental pharmacology & physiology
- 2019
- 1
Evidence based drug dosing and pharmacotherapeutic recommendations per genotype.
- Medicine
- Methods in molecular biology
- 2013
- 5
Towards the integration of pharmacogenetics in psychiatry: a minimum, evidence-based genetic testing panel
- Medicine
- Current opinion in psychiatry
- 2019
- 26
References
SHOWING 1-10 OF 14 REFERENCES
Genotype-guided dosing of coumarin derivatives: the European pharmacogenetics of anticoagulant therapy (EU-PACT) trial design.
- Medicine
- Pharmacogenomics
- 2009
- 142
- PDF
CYP2D6 and CYP2C19 genotype‐based dose recommendations for antidepressants:
a first step towards subpopulation‐specific dosages
- Medicine
- Acta psychiatrica Scandinavica
- 2001
- 406
Role of warfarin pharmacogenetic testing in clinical practice.
- Medicine, Biology
- Pharmacogenomics
- 2010
- 52
- PDF
A polymorphism in the VKORC1 gene is associated with an interindividual variability in the dose-anticoagulant effect of warfarin.
- Medicine
- Blood
- 2005
- 669
- PDF
Effect of VKORC1 haplotypes on transcriptional regulation and warfarin dose.
- Biology, Medicine
- The New England journal of medicine
- 2005
- 1,329
- PDF
Mutations in VKORC1 cause warfarin resistance and multiple coagulation factor deficiency type 2
- Biology, Medicine
- Nature
- 2004
- 1,047
Relative Impact of Genotype and Enzyme Induction on the Metabolic Capacity of CYP2C9 in Healthy Volunteers
- Biology, Medicine
- Clinical pharmacology and therapeutics
- 2009
- 35